Automated Microscopy Evaluation Study

NCT ID: NCT04558515

Last Updated: 2023-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

190 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Since the introduction of Giemsa stain in 1904 until today, malaria microscopy has been the standard of practice for malaria diagnosis. However, microscopic detection of malaria parasites is labour-intensive, time-consuming and expertise-demanding. Moreover, the slide interpretation is highly dependent on the staining technique and the technician's expertise.

To address these, multiple organisations have developed next generation microscopes to move towards a next generation microscope that can improve slide preparation, interpretation or data collection, or a combination of these features.

In this study, a prospective evaluation of miLabâ„¢ and other next generation automated microscope solutions as well as a malaria rapid diagnostic test (RDT) reader app will be performed in malaria-endemic countries to assess their clinical performance for detection of malaria clinical cases at POC.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malaria

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case

Symptomatic patients positive for malaria by PCR

Novel malaria diagnostics & tools

Intervention Type DIAGNOSTIC_TEST

Next generation microscopy tools for malaria diagnosis and medical applications

Control

Symptomatic patients negative for malaria by PCR

Novel malaria diagnostics & tools

Intervention Type DIAGNOSTIC_TEST

Next generation microscopy tools for malaria diagnosis and medical applications

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Novel malaria diagnostics & tools

Next generation microscopy tools for malaria diagnosis and medical applications

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 5 years or older
* Malaria status (positive or negative) established by microscopy at the health facility, where the patient is presenting
* Freely agreeing to participate by signing an informed consent form (adults aged 18 and older and parent/legal guardian of a child) and providing assent (children aged 13-17)
* Willing to provide finger prick blood sample at enrollment

Exclusion Criteria

* Having received antimalarial treatment during the preceding four-week period
* Presence of symptoms and signs of severe disease and/or central nervous system infections, as defined by WHO guidelines
Minimum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foundation for Innovative New Diagnostics, Switzerland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Endemic Diseases, Medical Campus

Khartoum, , Sudan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sudan

References

Explore related publications, articles, or registry entries linked to this study.

Hamid MMA, Mohamed AO, Mohammed FO, Elaagip A, Mustafa SA, Elfaki T, Jebreel WMA, Albsheer MM, Dittrich S, Owusu EDA, Yerlikaya S. Diagnostic accuracy of an automated microscope solution (miLab) in detecting malaria parasites in symptomatic patients at point-of-care in Sudan: a case-control study. Malar J. 2024 Jun 28;23(1):200. doi: 10.1186/s12936-024-05029-3.

Reference Type DERIVED
PMID: 38943203 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MA013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Malaria High-Risk Populations in Namibia
NCT04094727 COMPLETED PHASE4
Malaria in Early Life Study
NCT02001428 COMPLETED NA